Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy
2023-506088-33-00Phase 2Withdrawn
- Sponsor
- Aarhus University
- Start
- Nov 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allogeneic adipose tissue-derived mesenchymal stem cells in knee osteoarthritis (OA) (2 arms), sponsored by Aarhus University. Primary endpoints: Knee Injury and Osteoarthritis Score (KOOS), Pain diary (first 30 days) and 1 more. Planned start Nov 2023; status: withdrawn.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2023-506088-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506088-33-00.